[1]CurrentPatentAssignee:ASTRAZENECAPLC-WO2006/24823,2006,A1Locationinpatent:Page/Pagecolumn92
[1]Hickey,MichaelJ.;Allen,PaulH.;Caffrey,Moya;Hansen,Peter;Kingston,LeeP.;Wilkinson,DavidJ.[Journaloflabelledcompoundsandradiopharmaceuticals,2016,p.432-438]
[1]Hickey,MichaelJ.;Allen,PaulH.;Caffrey,Moya;Hansen,Peter;Kingston,LeeP.;Wilkinson,DavidJ.[Journaloflabelledcompoundsandradiopharmaceuticals,2016,p.432-438]
[1]Hickey,MichaelJ.;Allen,PaulH.;Caffrey,Moya;Hansen,Peter;Kingston,LeeP.;Wilkinson,DavidJ.[Journaloflabelledcompoundsandradiopharmaceuticals,2016,p.432-438]
Title: A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis.
Journal: The European respiratory journal 20151001
Title: Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
Journal: The Journal of pharmacology and experimental therapeutics 20150501
Title: Norman P. Evidence on the identity of the CXCR2 antagonist AZD-5069. Expert Opin Ther Pat. 2013 Jan;23(1):113-7.